エダラボンによる急性腎障害発現の危険因子解析

ORIGINAL ARTICLES

Risk factor of acute renal failure induced by edaravone in patients with cerebrovascular disorder

Author information

Yoshito ZAMAMI
Department of Emergency Pharmaceutics, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University
Hidenori SAGARA
Department of Pharmaceutical Information Sciences, Matsuyama University
Yuka KAYANO
Department of Emergency Pharmaceutics, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University
Toshihiro KOYAMA
Department of Pharmaceutics, Okayama University Hospital
Naoko SHIRAISHI
Department of Clinical PsychopharmacologyPharmacy, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University
Satoru ESUMI
Department of Clinical PsychopharmacologyPharmacy, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University
Toyomu UGAWA
Department of Traumatology and Emergency Intensive Care Medicine, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University
Toshiaki SENDO
Department of Clinical PsychopharmacologyPharmacy, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University
Yoshihito UJIKE
Department of Emergency and Critical Care Medicine, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University
Hironori NAKURA
Department of Clinical PsychopharmacologyPharmacy, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University

JOURNAL FREE ACCESS

2016 Volume 19 Issue 3 Pages 461-465

Details